Cite
HARVARD Citation
Lappegård, K. et al. (2018). Lipoprotein apheresis affects lipoprotein particle subclasses more efficiently compared to the PCSK9 inhibitor evolocumab, a pilot study. Transfusion and apheresis science. 57 (1), pp. 91-96. [Online].